Related Experiment Videos
TOBI: reducing the impact of pseudomonal infection
1Department of Medical Microbiology, University of Edinburgh Medical School, Edinburgh EH8 9AG.
Hospital Medicine (London, England : 1998)
|August 22, 2002
Abstract:
Pseudomonas aeruginosa infection is associated with impaired lung function and reduced life expectancy in cystic fibrosis patients. Tobramycin nebulizer solution (TOBI, Chiron Corporation Ltd, Hounslow) has been specifically formulated for use against P. aeruginosa infection in the lung.